- Home
- VKTX vs KFY Comparison
VKTX vs KFY Comparison
Compare VKTX & KFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VKTX | KFY |
|---|---|---|
| Founded | 2012 | 1969 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.9B |
| IPO Year | 2014 | 1998 |
Fundamental Metrics
Financial Performance| Metric | VKTX | KFY |
|---|---|---|
| Price | $27.05 | $76.53 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 21 | 5 |
| Target Price | ★ $95.32 | $90.50 |
| AVG Volume (30 Days) | ★ 4.8M | 478.9K |
| Earning Date | 10-28-2026 | 12-08-2026 |
| Dividend Yield | N/A | ★ 2.90% |
| EPS Growth | N/A | ★ 13.48 |
| EPS | N/A | ★ 1.32 |
| Revenue | N/A | ★ $1,819,519,000.00 |
| Revenue This Year | N/A | $20.33 |
| Revenue Next Year | N/A | $10.93 |
| P/E Ratio | ★ N/A | $57.17 |
| Revenue Growth | N/A | ★ 12.20 |
| 52 Week Low | $23.82 | $58.27 |
| 52 Week High | $43.15 | $87.51 |
Technical Indicators
Market Signals| Indicator | VKTX | KFY |
|---|---|---|
| Relative Strength Index (RSI) | 46.50 | 55.56 |
| Support Level | $26.47 | $70.22 |
| Resistance Level | $34.00 | $79.97 |
| Average True Range (ATR) | 1.53 | 2.15 |
| MACD | 0.27 | 0.63 |
| Stochastic Oscillator | 70.21 | 61.86 |
Price Performance
Historical ComparisonAbout VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
About KFY Korn Ferry
Korn Ferry is a world'wide consulting firm that powers individual and business performance. The impact it create spans entire organizations, but it always starts with people. The Company has eight reportable segments: Consulting, Digital, Executive Search North America, Executive Search EMEA, Executive Search Asia Pacific, Executive Search Latin America, Professional Search & Interim and RPO. The company generates majority of revenue from Consulting segment. Consulting helps clients design and implement the talent strategies, organizational structures, and workforce capabilities and rewards to drive growth. The company realigned its organizational structure by geography into three reportable segments: The Americas, EMEA, and Asia Pacific.